US · Healthcare · Diagnostics & Research
EPS came in at 4.99 against a street estimate of 4.79 — a beat of 4.2%.
Analysts rate Laboratory Corporation of America Holdings a buy (16 buy, 4 hold, 0 sell out of 20) with an average price target of $332.44.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.97% |
| Vanguard Capital Management, LLC | 6.65% |
| Victory Capital Management Inc. | 5.72% |
| State Street Corp | 4.78% |
| Vanguard Portfolio Management, LLC | 4.55% |
| Boston Partners Global Investors, Inc | 2.93% |
| Allspring Global Investments Holdings, LLC | 2.75% |
| Geode Capital Management, LLC | 2.70% |
| Document | Date |
|---|---|
| Results announced · Q3 2026 | 2026-07-30 |
| Reg FD disclosure · Q3 2026 | 2026-07-10 |
| Reg FD disclosure · Q2 2026 | 2026-06-30 |
| Reg FD disclosure · Q2 2026 | 2026-05-27 |
| Quarterly report · Q1 2026 | 2026-05-04 |
| Proxy statement · Q2 2026 | 2026-04-10 |
| Annual report FY2025 | 2026-02-24 |
| Quarterly report · Q3 2025 | 2025-10-31 |
Readable in the app.
| Announcement | Date |
|---|---|
| Board declares cash dividend of $0.72 per share Labcorp Holdings Inc. announced a quarterly cash dividend of $0.72 per share, payable on September 11, 2026, to shareholders of record as of August 28, 2026. This is a routine corporate acti | 2026-07-10 |
| Board declares cash dividend of $0.72 per share Labcorp Holdings Inc. (NYSE: LH), a major laboratory services company, announced a quarterly cash dividend of $0.72 per share, declared by its Board of Directors on April 9, 2026. Shareholde | 2026-04-09 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Laboratory Corporation of America Holdings — free to start.
Google PlayApp StoreData updated 2026-08-05.